Trial managers worldwide have been focusing on specific regions for placing their clinical trials. So much so that about 60-70% of clinical trials globally are conducted in USA and Europe alone. However, this is slated to change or should change, if one consults a recent white paper published by Frost & Sullivan. The white paper […]

Read More →

Investigators, from Brazil and specialized in Allergy and Immunology segment, are invited to participate in feasibility of a new phase II clinical trial.     What’s this trial about? It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil.   What kind of patients are required for this […]

Read More →